SCHEMBL8264116

SCHEMBL8264116

Cc1cccc(-c2ccc3c(c2)C(=O)NC3)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 4/20 1.00
DYRK1B Q9Y463 2/20 1.00
FYN P06241 1/20 1.00
NTRK2 Q16620 3/20 0.71
TYRO3 Q06418 1/20 0.71
PARP10 Q53GL7 2/20 0.61
PARP11 Q9NR21 1/20 0.61
NTRK1 P04629 3/20 0.60
FLT3 P36888 3/20 0.60
KDR P35968 3/20 0.60
GSK3B P49841 2/20 0.60
MET P08581 2/20 0.60
NTRK3 Q16288 2/20 0.60
JAK2 O60674 1/20 0.60
FGFR1 P11362 1/20 0.60
PRKACA P17612 1/20 0.60
MAP2K2 P36507 1/20 0.60
MAP2K1 Q02750 1/20 0.60
MST1R Q04912 1/20 0.60
CAMK1D Q8IU85 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13680532 0.88 CLK4 (0.78) CLK4DYRK1BFYNNTRK2TYRO3
SCHEMBL29985572 0.85 CLK4 (0.74) CLK4DYRK1BFYNNTRK2TYRO3
SCHEMBL19187116 0.85 CLK4 (0.74) CLK4DYRK1BFYNNTRK2TYRO3
SCHEMBL13618609 0.84 CLK4 (0.73) CLK4DYRK1BFYNNTRK2TYRO3
SCHEMBL8723086 0.83 CLK4 (1.00) CLK4DYRK1BFYNNTRK2TYRO3
SCHEMBL30560110 0.81 PARP10 (0.68) CLK4DYRK1BFYNNTRK2TYRO3
SCHEMBL149199 0.81 PARP10 (0.68) CLK4DYRK1BFYNNTRK2TYRO3
SCHEMBL23137953 0.77 CLK4 (0.69) CLK4DYRK1BFYNNTRK2TYRO3
SCHEMBL22643292 0.77 CLK4 (0.62) CLK4DYRK1BFYNNTRK2TYRO3
SCHEMBL25920352 0.76 CLK4 (0.73) CLK4DYRK1BFYNNTRK2TYRO3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2177518-A1 Organic compounds Novartis AG (CH) 2010-04-21 EP disclosed
WO-2006069788-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2006-07-06 WO disclosed